Incidence of soft tissue sarcoma and beyond: A population-based prospective study in 3 European regions

Cancer

Volumn 118, Issue 21, 2012, Pages 5339-5348

  Mastrangelo, Giuseppe ^a   Coindre, Jean Michel ^b   Ducimetière, Françoise ^c   Dei Tos, Angelo Paolo ^d   Fadda, Emanuela ^a   Blay, Jean Yves ^c   Buja, Alessandra ^a   Fedeli, Ugo ^e   Cegolon, Luca ^a,f   Frasson, Alvise ^a   Ranchère Vince, Dominique ^c   Montesco, Cristina ^a   Ray Coquard, Isabelle ^c   Rossi, Carlo Riccardo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b INSTITUT BERGONIÉ   (France)

^c UNIVERSITÉ DE LYON   (France)

^d Treviso General Hospital   (Italy)

^e Veneto Region   (Italy)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

cancer incidence; epidemiology; pathologist; sarcoma; World Health Organization classification

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARM; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER STATISTICS; CHILD; CONTROLLED STUDY; DERMATOFIBROSARCOMA PROTUBERANS; DIGESTIVE SYSTEM CANCER; FEMALE; GEOGRAPHIC DISTRIBUTION; HEAD; HISTOPATHOLOGY; HOSPITAL DISCHARGE; HUMAN; INFANT; JOINT CANCER; LEG; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MALE; NECK; OSTEOSARCOMA; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; RETROPERITONEUM; REVIEW; SCHOOL CHILD; SEX DIFFERENCE; SOFT TISSUE SARCOMA; TREND STUDY; TRUNK; UTERUS SARCOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 84867850606     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27555     Document Type: Review

References (35)

1. American Cancer Society. What is a soft tissue sarcoma? Available at: http://www.cancer.org/cancer/sarcoma-adultsofttissuecancer/detailedguide/ sarcoma-adult-soft-tissue-cancer-soft-tissue-sarcoma. Accessed August 6, 2011.
2. Fletcher CDM, Unni KK, Mertens F, eds. Pathology and Genetics of Tumors of Soft Tissue and Bone. WHO Classification of Tumours. Lyon, France: IARC Press; 2002.
3. Arbiser ZK, Folpe AL, Weiss SW,. Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol. 2001; 116: 473-476.
4. Harris M, Hartley AL, Blair V, et al. Sarcomas in north west England: I. Histopathological peer review. Br J Cancer. 1991; 64: 315-320.
5. Mastrangelo G, Fadda E, Cegolon L, et al. A European project on incidence, treatment, and outcome of sarcoma [serial online]. BMC Public Health. 2010; 10: 188.
6. Higginson J, Muir CS,. Epidemiology. In:, Holland JF, Frei E, eds. Cancer Medicine. Philadelphia, PA: Lea and Febiger; 1973: 241-306.
7. Lehnhardt M, Daigeler A, Hauser J, et al. The value of expert second opinion in diagnosis of soft tissue sarcomas. J Surg Oncol. 2008; 97: 40-43.
8. Thway K, Fisher C,. Histopathological diagnostic discrepancies in soft tissue tumours referred to a specialist centre [serial online]. Sarcoma. 2009; 2009: 741975.
9. Lurkin A, Ducimetiere F, Vince DR, et al. Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region [serial online]. BMC Cancer. 2010; 10: 150.
10. Fisher C,. Diagnosing sarcomas: the role of experience. Diagn Histopathol. 2011; 17: 333-339.
11. Toro JR, Travis LB, Wu HJ, et al. Incidence patterns of soft tissue sarcomas, regardless of primary site, in the Surveillance, Epidemiology and End Results Program, 1978-2001: an analysis of 26,758 cases. Int J Cancer. 2006; 119: 2922-2930.
12. Daugaard S,. Current soft-tissue sarcoma classifications. Eur J Cancer. 2004; 40: 543-548.
13. Wibmer C, Leithner A, Zielonke N, Sperl M, Windhager R,. Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. Ann Oncol. 2010; 21: 1106-1111.
14. AIRT Working Group. Italian cancer figures-report 2006: incidence, mortality and estimates. Epidemiol Prev. 2006; 30 (1 suppl 2): 8-10.
15. Ducimetiere F, Lurkin A, Ranchere-Vince D, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing [serial online]. PLoS One. 2011; 6: e20294.
16. Rubio J, Marcos-Gragera R, Ortiz MR, et al. Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain. Eur J Cancer. 2007; 43: 144-148.
17. Mazzola P, Spitale A, Banfi S, Mazzucchelli L, Frattini M, Bordoni A,. Epidemiology and molecular biology of gastrointestinal stromal tumors (GISTs): a population-based study in the South of Switzerland, 1999-2005. Histol Histopathol. 2008; 23: 1379-1386.
18. Tryggvason G, Gislason HG, Magnusson MK, Jonasson JG,. Gastrointestinal stromal tumors in Iceland, 1990-2003: the Icelandic GIST Study, a population-based incidence and pathologic risk stratification study. Int J Cancer. 2005; 117: 289-293.
19. Perez EA, Livingstone AS, Franceschi D, et al. Current incidence and outcomes of gastrointestinal mesenchymal tumors including gastrointestinal stromal tumors. J Am Coll Surg. 2006; 202: 623-629.
20. Iscovich J, Boffetta P, Winkelmann R, Brennan P, Azizi E,. Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study. AIDS. 1998; 12: 2067-2072.
21. Qubaiah O, Devesa SS, Platz CE, Huycke MM, Dores GM,. Small intestinal cancer: a population-based study of incidence and survival patterns in the United States, 1992 to 2006. Cancer Epidemiol Biomarkers Prev. 2010; 19: 1908-1918.
22. Jawad MU, Cheung MC, Min ES, Schneiderbauer MM, Koniaris LG, Scully SP,. Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005. Cancer. 2009; 115: 3526-3536.
23. Cleton-Jansen AM, van Beerendonk HM, Baelde HJ, Bovee JV, Karperien M, Hogendoorn PC,. Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma. Clin Cancer Res. 2005; 11: 8028-8035.
24. Simpson ER,. Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 2003; 86: 225-230.
25. Sylvestre VT, Dunton CJ,. Treatment of recurrent endometrial stromal sarcoma with letrozole: a case report and literature review. Horm Cancer. 2010; 1: 112-115.
26. Ioffe YJ, Li AJ, Walsh CS, et al. Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles. Gynecol Oncol. 2009; 115: 466-471.
27. Alkasi O, Meinhold-Heerlein I, Zaki R, et al. Long-term disease-free survival after hormonal therapy of a patient with recurrent low grade endometrial stromal sarcoma: a case report. Arch Gynecol Obstet. 2009; 279: 57-60.
28. O'Cearbhaill R, Zhou Q, Iasonos A, et al. Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors. Gynecol Oncol. 2010; 116: 424-429.
29. Chaudhuri PK, Walker MJ, Beattie CW, Das Gupta TK,. Presence of steroid receptors in human soft tissue sarcomas of diverse histological origin. Cancer Res. 1980; 40: 861-865.
30. Li XQ, Hisaoka M, Hashimoto H,. Expression of estrogen receptors alpha and beta in soft tissue sarcomas: immunohistochemical and molecular analysis. Pathol Int. 2003; 53: 671-679.
31. Greenberg JA, Somme S, Russnes HE, Durbin AD, Malkin D,. The estrogen receptor pathway in rhabdomyosarcoma: a role for estrogen receptor-beta in proliferation and response to the antiestrogen 4'OH-tamoxifen. Cancer Res. 2008; 68: 3476-3485.
32. Dohi O, Hatori M, Suzuki T, et al. Sex steroid receptors expression and hormone-induced cell proliferation in human osteosarcoma. Cancer Sci. 2008; 99: 518-523.
33. Tabb MM, Blumberg B,. New modes of action for endocrine-disrupting chemicals. Mol Endocrinol. 2006; 20: 475-482.
34. Mnif W, Hassine AI, Bouaziz A, Bartegi A, Thomas O, Roig B,. Effect of endocrine disruptor pesticides: a review. Int J Environ Res Public Health. 2011; 8: 2265-2303.
35. Hoppin JA, Tolbert PE, Flanders WD, et al. Occupational risk factors for sarcoma subtypes. Epidemiology. 1999; 10: 300-306.